The Income Tax Department has conducted searches on a prominent Bengaluru-based pharmaceutical group, which manufactures and markets pharmaceutical products and APIs, with a global presence in over 50 countries. The operation, covering 36 premises across nine states, uncovered significant incriminating documents and digital data. Initial findings suggest the group debited unallowable expenses for freebies like travel and gifts to medical professionals, estimated at around ₹1000 crore, to promote its products. Additionally, the group is suspected of tax evasion through inflated deductions, suppressed expenses, and inadequate allocation of R&D costs, potentially evading over ₹300 crore in taxes. Unaccounted cash and jewellery were also seized.
Income Tax Department carried out search and seizure operations on 06.07.2022 on a major Bengaluru-based pharmaceutical group, engaged in the business of manufacturing and marketing of pharmaceutical products and Active Pharmaceutical Ingredients (API). The group has presence in over 50 countries. T
Daily Limit Reached
You have reached your daily limit of 2 Free News
Subscribe to
CCI PRO
for unlimited access
Why Upgrade to
CCI PRO?
-
No Ads
-
WhatsApp Broadcasts
-
Daily E-Newsletter
-
Unlimited News Access
BEST VALUE
2 YEAR PLAN
3,499
(Inclusive of GST)
1 YEAR PLAN
1,999
(Inclusive of GST)
View all CCI PRO benfits
Already a PRO member?
Login here
for an ad-free experience.
FAQ :
The Income Tax Department carried out search and seizure operations on 06.07.2022.
A major Bengaluru-based pharmaceutical group engaged in manufacturing and marketing pharmaceutical products and Active Pharmaceutical Ingredients (API) was searched.
The search action covered approximately 36 premises spread across 9 States.
The search was conducted due to allegations of tax evasion, including the debiting of unallowable expenses for freebies provided to medical professionals, estimated at around ₹1000 crore.
Other detected methods include claiming artificially inflated deductions, suppression of expenses, over-appropriation of revenue, inadequate allocation of R&D expenses, and inflated claims for weighted deduction under section 35 (2AB).
Substantial incriminating evidence in the form of documents and digital data was seized. Additionally, unaccounted cash amounting to ₹1.20 crore and unaccounted gold and diamond jewellery worth over ₹1.40 crore were also seized.